Involvement of nitric oxide pathway in the PAF‐induced relaxation of rat thoracic aorta

British Journal of Pharmacology

Volumn 107, Issue 1, 1992, Pages 196-201

  Moritoki, Hideki ^a   Hisayama, Tetsuhiro ^a   Takeuchi, Shougo ^a   Miyano, Hiroaki ^a   Kondoh, Wataru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

aging; cyclic GMP; haemoglobin; methylene blue; NG nitro l arginine (l NNA); nitric oxide; PAF; relaxation

Indexed keywords

1 METHYL 3 [1 [5 METHYLTHIOMETHYL 6 OXO 3 (2 OXO 3 CYCLOPENTEN 1 YLIDENE) 2 PIPERAZINYL]ETHYL] 2 INDOLINONE; 2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; CYCLIC AMP; CYCLIC GMP; HEMOGLOBIN; METHYLENE BLUE; N(G) NITROARGININE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

AGE; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; THORAX;

AGING; ANIMAL; AORTA, THORACIC; ARGININE; CYCLIC AMP; CYCLIC GMP; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HEMOGLOBINS; MALE; METHYLENE BLUE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PLATELET ACTIVATING FACTOR; PYRIDINIUM COMPOUNDS; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T;

EID: 0026663119     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1992.tb14486.x     Document Type: Article

References (34)

1. Platelet activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils
2. Metabolism of 1‐alkyl‐2‐acetyl‐sn‐glycero‐3‐phosphocholine by cell cultures
3. Aortic vascular and arterial responses to (±)‐1‐O‐octadecyl‐2‐acetyl‐glyceryl‐3‐phosphorylcholine
4. Endothelium‐dependent relaxant action of platelet activating factor in the rat mesenteric artery
5. Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog
6. PAF‐acether‐induced synthesis of prostacyclin by human endothelial cells
7. Effect of platelet‐activating factor on airway vascular permeability: possible mechanisms
8. Reproducible vasodilatation by platelet‐activating factor in blood and Krebs‐perfused rat kidneys is albumin‐dependent
9. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite
10. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small‐volume samples from blood and tissue
11. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation
12. Endothelium‐dependent vasodilator effects of platelet activating factor on rat resistance vessels
13. Mechanism(s) of the hypotensive effect of synthetic 1‐O‐octadecyl‐2‐O‐acetyl‐glycero‐3‐phosphorylcholine
14. Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF)
15. Nitroarginine inhibits endothelium‐derived relaxation
16. Hypotensive and vasodilatory activity of (±) 1‐O‐octadecyl‐2‐acetyl glyceryl‐3‐phosphorylcholine in the normotensive rat
17. Selective blockade of endothelium‐dependent and glyceryl trinitrate‐induced relaxation by hemoglobin and by methylene blue in the rabbit aorta
18. Age‐related decrease in endothelium‐dependent dilator response to histamine in rat mesenteric artery
19. Evidence for the involvement of cyclic GMP in adenosine‐induced, age‐dependent vasodilatation
20. Age‐associated decrease in histamine‐induced vasodilatation may be due to reduction of cyclic GMP formation
21. Possible mechanisms of age‐associated reduction of vascular relaxation caused by atrial natriuretic peptide
22. G‐[imino‐(nitro‐amino)methyl]‐L‐ornitine) impairs endothelium‐dependent dilations by inhibiting cytosolic nitric oxide synthesis from L‐arginine
23. Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR‐900452 in animal models
24. Agonist‐induced endothelium‐dependent relaxation in rat thoracic aorta may be mediated through cGMP.
25. Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP level and relaxation in rat aorta
26. Characteristics of endothelial nitric oxide synthase in vitro and in vivo
27. Platelet activating factor analogues: lack of correlation between their activities to produce hypotension and endothelium‐mediated vasodilation
28. Potentiation by bovine serum albumin (BSA) of endothelium‐dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC)
29. Studies on the hypotensive effects of platelet activating factor (PAF, 1‐O‐alkyl‐2‐acetyl‐sn‐glyceryl‐3‐phosphorylcholine) in rats, guinea pigs, rabbits, and dogs
30. CV‐6209, a highly potent antagonist of platelet activating factor in vitro and in vivo
31. CV‐3988 — a specific antagonist of platelet activating factor (PAF)
32. Possible association of decrease of ATP‐induced vascular relaxation with reduction fo cyclic GMP during aging
33. Platelets, endothelium, and vasospasm
34. PAF antagonists: different effects on platelets, neutrophils, guinea‐pig ileum and PAF‐induced vasodilation in isolated rat lung